Robin Hood Ventures
VC Fund
Philadelphia, United States
Robin Hood Ventures is a group of angel investors, focused on early-stage, high-growth companies in the Greater Philadelphia region. We help entrepreneurs build great companies, providing capital, mentoring, expertise and connections to help companies reach their potential. Robin Hood generally invests $250k to $500k, and collaborates with angels,institutions and VCs in our network. We invest as a single entity in businesses we know and understand, in a way that gets deals done. Since 1999, we have invested in over 45 companies in industries including software, medical devices, biotech, internet and financial technology.
- Total investments:
- 161
- Last investment:
- Lead investor:
- 8%
Last updated:
For AI agents: llms.txt
Industries Robin Hood Ventures invests in
Stages Robin Hood Ventures invests in
Countries Robin Hood Ventures invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $210k–$4.3M
- Series A
- $100k–$11M
Investment Focus
Industry
- Software 22 (14%)
- Health Care 21 (13%)
- Biotechnology 18 (11%)
- Medical 10 (6%)
- SaaS 9 (6%)
Stage
- Seed 30 (19%)
- Series A 24 (15%)
- Convertible Note 22 (14%)
- Funding Round 20 (12%)
- Series B 8 (5%)
Country
- United States 75 (47%)
- Canada 1 (1%)
- Israel 1 (1%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Allen Fogel
Partner
|
Partner | Total investments: 2 | Find email | |
Donna Cordner
Managing Partner
|
Managing Partner | Total investments: 2 | Find email | |
Ellen Weber
Executive Director
|
Executive Director | Total investments: 0 | Find email | |
Glen Gaddy
Managing Member
|
Managing Member | Total investments: 2 | Find email | |
Jack Butler
Member
|
Member | Total investments: 0 | Find email | |
| See all 9 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Cooler Heads
|
Cooler Heads develops cold caps designed for chemotherapy patients. | $3.3M / Series A / Jul 23, 2026 | |
Surface Design Solutions
|
Surface Design Solutions works with manufacturers to develop customized surface metrics that extend product lifetimes and improve product performance. The company utilizes physics-informed machine learning to determine the surface metrics to predict desired performance. | $320K / Seed / Jul 01, 2026 | |
Aseon Labs
|
Aseon Labs builds robotic pitstops for self-driving cars that provide charging, cleaning, and inspection for autonomous fleets directly in operating zones. The company develops modular robotic vehicle stations, referred to as Aseon Pods, that function as depots in a box rather than centralized facilities. These stations are designed to supportautonomous vehicles with routine turnaround tasks so that vehicles can remain near demand instead of traveling to distant depots. Aseon Labs focuses on the operational infrastructure layer for autonomous mobility, offering hardware and software systems that manage robotic station operation. Its products are intended for autonomous fleet operators and mobility companies that need distributed, always-on infrastructure to keep vehicles available. The company positions its technology for use across urban operating areas where autonomous vehicles run continuous services. | $10M / Seed / Jun 26, 2026 | |
|
Cooler Heads
|
Cooler Heads develops cold caps designed for chemotherapy patients. | $11M / Series A / Jul 22, 2025 | |
FEMSelect
|
FEMSelect is making a lasting impact on women's health by delivering an innovative technology platform. It is the developer of EnPlace, a minimally invasive and mesh-free system for pelvic floor ligament fixation. Using EnPlace takes approximately 30 minutes. The patented delivery system enables the precise guidance, insertion, anddeployment of the anchor unit. The anchor is designed to be introduced through the vaginal wall and secured to the pelvic floor ligament to provide stabilization.FEMSelect was founded in 2012 and is headquartered in Modi’in, Israel. | Series B / May 13, 2025 | |
Integrated Reality Labs
|
Integrated Reality Labs (IRL Inc.) builds integrated reality (IR) games and tools that enhance play in the real world. Our patent pending Integrated Reality Technology Platform leverages UWB, bluetooth + mobile location services & other device sensors to power all of IRL’s products, starting with SLAP. SLAP is a mobile app that digitallytransforms IRL games - like Assassin, HvZ, Capture the Flag, Manhunt & Tag - making them more fun and easier to play anytime, anywhere, and with anyone.IRL inc is in the process of using the IRTP to empower end users to create, share, and monetize their own mobile powered real world games... a la the Roblox if IRL Games. | $205K / Feb 01, 2025 | |
Vessl Prosthetics
|
Vessl Prosthetics is a prosthetics firm that is driven by the idea of empowering amputees and their champions to overcome challenges and realize their full potential. The objective is to revolutionize how amputees engage with prosthetic devices by developing new, inexpensive, and accessible alternatives. | $250K / Pre-Seed / Jan 17, 2025 | |
BrilliantPad
|
BrilliantPet introduces smart self-cleaning dog potty. The product is an automatic, convenient and self-cleaning indoor waste disposal product for dogs. They provide a more convenient and healthier potty solution that brings peace of mind to dogs and pet parents. | $17K / Nov 01, 2024 | |
Virion Therapeutics
|
Virion Therapeutics is a science-driven company developing innovative immune-based treatments for virally associated cancers and chronic viral infections. Their vaccines, ChiVax and ChiVax-gD, represent novel and highly effective platforms to induce potently and sustained T cell-mediated immune responses against transformed or infected cells,thereby targets common diseases with unmet medical needs. Each component comprising chimeric vaccine candidates has completed pre-clinical testing that allows for their translation into clinical trials for several different indications. Guided by their scientific and management expertise, these platforms may help cure such devastating diseases as HPV-induced cancers and chronic Hepatitis B infections.Virion Therapeutics was founded in 2018 and is headquartered in Newark, Delaware. | $95K / Oct 01, 2024 | |
Vytala
|
Vytala is a food tech firm focused on improving nutrition through innovative solutions. | Pre-Seed / Sep 19, 2024 | |
| See all 161 investments → | |||
Co-Investors
Delaware Crossing Investor Group
11 deals together
Ben Franklin Technology Partners of Southeastern Pennsylvania
9 deals together
New York Angels
6 deals together
SOSV
5 deals together
Emerald Development Managers
4 deals together
MentorTech Ventures
4 deals together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Robin Hood Ventures invest in?
Robin Hood Ventures invests primarily in Software, Health Care and Biotechnology startups, most often at Seed and Series A stage. Most of the 161 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Robin Hood Ventures's check size?
Robin Hood Ventures typically joins rounds of $210k–$4.3M at Seed and $100k–$11M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Robin Hood Ventures participates in.
How do I contact Robin Hood Ventures?
Public channels for Robin Hood Ventures include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Robin Hood Ventures?
The team at Robin Hood Ventures includes Allen Fogel (Partner), Donna Cordner (Managing Partner) and Ellen Weber (Executive Director), among 9 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
